Get the Stockscreener App
2.585
0.34%
-0.005
Theratechnologies Inc stock is traded at $2.585, with a volume of 7,933.
It is down -0.34% in the last 24 hours and down -9.91% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$2.59
Open:
$2.58
24h Volume:
7,933
Relative Volume:
0.00
Market Cap:
$119.55M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-51.70
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
-0.34%
1M Performance:
-9.91%
6M Performance:
+113.31%
1Y Performance:
+103.24%
1-Day Range:
$2.5715
$2.615
1-Week Range:
$2.54
$2.68
52-Week Range:
$1.12
$3.13
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
2.60 | 117.25M | 84.32M | -3.16M | -4.50M | -0.05 |
|
ONC
Beone Medicines Ltd Adr
|
244.91 | 25.57B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.11 | 111.79B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2901 | 39.90M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.61 | 65.28B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.69 | 6.31B | 0 | -153.72M | -103.81M | -2.00 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
(TH) Technical Patterns and Signals (TH:CA) - news.stocktradersdaily.com
(TH) Stock Evaluation Report (TH:CA) - news.stocktradersdaily.com
Learn to Evaluate (TH) using the Charts (TH:CA) - news.stocktradersdaily.com
(TH) Investment Report (TH:CA) - news.stocktradersdaily.com
Raymond James Financial Inc. Makes New $27,000 Investment in Theratechnologies Inc. (NASDAQ:THTX) - Defense World
(TH) Investment Analysis and Advice (TH:CA) - news.stocktradersdaily.com
Objective long/short (TH) Report (TH:CA) - news.stocktradersdaily.com
Analyzing Theratechnologies (NASDAQ:THTX) and NexImmune (NASDAQ:NEXI) - Defense World
JPMorgan Chase & Co. Buys New Stake in Theratechnologies Inc. (NASDAQ:THTX) - Defense World
When the Price of (TH) Talks, People Listen (TH:CA) - news.stocktradersdaily.com
Theratechnologies, Inc. to Host Earnings Call - ACCESS Newswire
(TH) Market Performance Analysis (TH:CA) - news.stocktradersdaily.com
Theratechnologies announces annual shareholder meeting By Investing.com - Investing.com Canada
Theratechnologies announces annual shareholder meeting - Investing.com Australia
Theratechnologies to Hold Virtual Annual Shareholder Meeting on May 29, 2025 - TipRanks
Stocks In Play: Theratechnologies Inc. By Baystreet.ca - Investing.com Canada
Theratechnologies Inc. - MENAFN.com
Stocks In Play: Theratechnologies Inc. - Barchart.com
Aegis Brands Inc. - Baystreet.ca
Theratechnologies (THTX) Presents Data on Visceral Fat and Muscle Quality in HIV | THTX Stock News - GuruFocus
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV - The Manila Times
Theratechnologies Presents Novel Data at ACTHIV 2025 - GlobeNewswire
(TH) Stock Market Analysis (TH:CA) - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
(TH) Advanced Trading Insights (TH:CA) - news.stocktradersdaily.com
(TH) Pivots Trading Plans and Risk Controls (TH:CA) - news.stocktradersdaily.com
Is Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
Theratechnologies to further evaluate potential sale of company - MSN
Theratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 Offer (NASDAQ:THTX) - Seeking Alpha
What is Leede Financial’s Forecast for THTX FY2025 Earnings? - Defense World
Theratechnologies Evaluates Potential Sale Amid Future Pak Proposal - TipRanks
Theratechnologies (THTX) Explores Sale Amid Ongoing Discussions - GuruFocus
What is Leede Financial’s Estimate for THTX FY2026 Earnings? - Defense World
Theratechnologies (THTX) Explores Potential Sale Amidst Future P - GuruFocus
Theratechnologies Provides Update on Sale Process - GlobeNewswire
Major Acquisition Alert: Theratechnologies Opens Sale Process Following Buyout Interest - Stock Titan
Theratechnologies Engages in Exclusive Acquisition Talks - TipRanks
Theratechnologies Provides Update on Sale Process | THTX Stock N - GuruFocus
Soleus Capital Urges Theratechnologies (THTX) Acquisition - GuruFocus
Theratechnologies can do better than the Future Pak offer, Leede says - Cantech Letter
Crude Oil Moves Lower; M&T Bank Earnings Miss Views - Benzinga
Trend Tracker for (TH) (TH:CA) - news.stocktradersdaily.com
Analyst Reveals Undervalued Pharmaceutical Gem in Canada - streetwisereports.com
Future Pak submits proposals to acquire Theratechnologies - MSN
Theratechnologies Hits 52-Week High As Acquisition Talks Heat Up - Finimize
Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News
Theratechnologies in talks with anonymous potential buyer while fielding Future Pak buyout offer - PharmaLive
Theratechnologies in Talks with Anonymous Potential Buyer While Fielding Future Pak Buyout Offer - BioSpace
Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak - Fierce Pharma
Future Pak Proposes Acquisition of Theratechnologies (THTX) - GuruFocus
Theratechnologies (THTX) Urged to Consider Acquisition Offer by Soleus Capital | THTX Stock News - GuruFocus
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):